Kalaris Therapeutics, Inc. (ALVR)
Market Open
18 Mar, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
9. 81
+0.39
+4.14%
$
49.48M Market Cap
- P/E Ratio
0% Div Yield
9,402 Volume
-1.75 Eps
$ 9.42
Previous Close Day Range
9.55 10.32
Year Range
7.96 24.15
Want to track ALVR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ALVR Kalaris Therapeutics, Inc. 10 Nov 2025 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 7 Aug 2025 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 6 Jun 2025 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 13 Mar 2025 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 31 Oct 2024 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 1 Aug 2024 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 6 Jun 2024 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 2 May 2024 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 13 Feb 2024 | | - | - |
| ALVR Kalaris Therapeutics, Inc. 1 Nov 2023 | | - | - |
ALVR Earnings Reports FAQ
What is the earnings per share (EPS) for ALVR?
The current EPS is -1.75.
What is the company's earnings growth rate?
Kalaris Therapeutics, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Kalaris Therapeutics, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Kalaris Therapeutics, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ALVR at this time, as Kalaris Therapeutics, Inc has no recent EPS data to calculate it.
